Faeth Therapeutics, Inc. current ratio

The Current Ratio as of November 2026 (TTM) for Faeth Therapeutics, Inc. (FTH) is 19.69

According to Faeth Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 19.69. This represents a change of 75.21% compared to the average of 11.24 of the last 4 quarters.

Faeth Therapeutics, Inc. (FTH) Historical Current Ratio (quarterly & annually)

How has FTH Current Ratio performed in the past?

The mean historical Current Ratio of Faeth Therapeutics, Inc. over the last ten years is 8.96. The current 19.69 Current Ratio has changed 119.74% with respect to the historical average. Over the past ten years (40 quarters), FTH's Current Ratio was at its highest in in the March 2021 quarter at 69.81. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Faeth Therapeutics, Inc. (FTH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Faeth Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Faeth Therapeutics, Inc. (FTH) Average Current Ratio

How has FTH Current Ratio performed in the past?

The current Current Ratio of Faeth Therapeutics, Inc. (FTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Faeth Therapeutics, Inc. (FTH) Current Ratio vs. Peers

How is FTH’s Current Ratio compared to its peers?

Faeth Therapeutics, Inc.’s Current Ratio is less than Tango Therapeutics, Inc. (50.82), greater than Puma Biotechnology, Inc. (2.91), greater than Nuvation Bio Inc. (8.37), greater than Prelude Therapeutics Incorporated (4.07), greater than Kura Oncology, Inc. (4.73), greater than Verastem, Inc. (2.25), greater than Relay Therapeutics, Inc. (18.27), greater than Boundless Bio, Inc. (9.48), greater than Janux Therapeutics, Inc. (16.35), greater than Kazia Therapeutics Ltd ADR (2.87),

Build a custom stock screener for Faeth Therapeutics, Inc. (FTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Faeth Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Faeth Therapeutics, Inc. (FTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Faeth Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.